Specific Effects of Anorexia Nervosa and Obesity on Bone Mineral Density and Bone Turnover in Young Women.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
01 04 2020
Historique:
received: 17 06 2019
accepted: 09 12 2019
pubmed: 11 12 2019
medline: 5 1 2021
entrez: 11 12 2019
Statut: ppublish

Résumé

The threefold aim was to (1) compare areal bone mineral density (aBMD), bone turnover markers, and periostin levels in young women with either anorexia nervosa (AN) or obesity (OB) and controls (CON); (2) model the profiles according to age; and (3) determine the parameters associated with aBMD. One hundred and fifty-two young women with ages ranging from 16.0 to 27.0 years were subdivided into 3 groups (AN, OB, CON). The CON group was age-matched by ±6 months. aBMD, bone turnover markers, and periostin levels were evaluated. aBMD modeling showed that hip aBMD was higher in OB than in the other 2 groups from 19 years, and AN presented lower values than CON from 21 years. aBMD at the lumbar spine was higher in older OB and CON women, starting from 20 to 22 years, but in AN the difference with the other 2 groups increased with age. Periostin levels were lower in OB than in AN or CON, but no variation with age was observed. Compared with controls, OB and AN presented similarly lower markers of bone formation, although markers of bone resorption were lower in OB and higher in AN. A modeling approach showed that markers of bone formation and resorption were lower in older than in younger CON, whereas the values of these bone markers remained relatively constant in AN and OB. In all groups, lean body mass (LBM) was the parameter most positively correlated with aBMD. This study demonstrated that weight extremes (AN or OB) influence aBMD, bone remodeling and periostin profiles. Moreover, factors related to aBMD were specific to each condition, but LBM was the parameter most consistently associated with aBMD.

Identifiants

pubmed: 31821467
pii: 5672712
doi: 10.1210/clinem/dgz259
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Endocrine Society 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Laurent Maïmoun (L)

Département de Médecine Nucléaire, Hôpital Lapeyronie, Centre Hospitalier Régional Universitaire (CHRU) Montpellier, Montpellier, France.
PhyMedExp, Université de Montpellier (UM), INSERM, CNRS, Montpellier, France.

Patrick Garnero (P)

INSERM Research Unit 1033, Lyon, France.

Thibault Mura (T)

Unité de Recherche Clinique et Epidémiologie, Hôpital Lapeyronie, CHRU Montpellier, Montpellier, France.

David Nocca (D)

Département de Chirurgie Digestive, Hôpital St Eloi, CHRU Montpellier.

Patrick Lefebvre (P)

Departement d'Endocrinologie, Diabète, Nutrition, Hôpital Lapeyronie, CHRU Montpellier, Montpellier, France.

Pascal Philibert (P)

Departement de Biochimie et d'Hormonologie, Hôpital Lapeyronie, CHRU Montpellier, Montpellier, France.

Maude Seneque (M)

Département d'Urgence et Post-Urgence Psychiatrique, Hôpital Lapeyronie, CHRU Montpellier, UM, INSERM U1061, Montpellier, France.

Laura Gaspari (L)

Unité d'Endocrinologie et Gynécologie Pédiatrique, Département de Pédiatrie, Hôpital Arnaud de Villeneuve, CHRU Montpellier et UM, Montpellier, France.

Fabien Vauchot (F)

Département de Médecine Nucléaire, Hôpital Lapeyronie, Centre Hospitalier Régional Universitaire (CHRU) Montpellier, Montpellier, France.

Philippe Courtet (P)

Département d'Urgence et Post-Urgence Psychiatrique, Hôpital Lapeyronie, CHRU Montpellier, UM, INSERM U1061, Montpellier, France.

Ariane Sultan (A)

PhyMedExp, Université de Montpellier (UM), INSERM, CNRS, Montpellier, France.
Département Endocrinologie, Nutrition, Diabète; Equipe Nutrition, Diabète, Hôpital Lapeyronie, CHRU Montpellier, Montpellier, France.

Marie-Liesse Piketty (ML)

Laboratoire des Explorations Fonctionnelles, Hôpital Necker, Paris, France.

Charles Sultan (C)

Unité d'Endocrinologie et Gynécologie Pédiatrique, Département de Pédiatrie, Hôpital Arnaud de Villeneuve, CHRU Montpellier et UM, Montpellier, France.

Eric Renard (E)

Departement d'Endocrinologie, Diabète, Nutrition, Hôpital Lapeyronie, CHRU Montpellier, Montpellier, France.
CIC INSERM 1001, Hôpital Gui de Chauliac, CHRU Montpellier, France.
Institut de Génomique Fonctionnelle, CNRS UMR 5203/INSERM U661/UM, Montpellier, France.

Sébastien Guillaume (S)

Département d'Urgence et Post-Urgence Psychiatrique, Hôpital Lapeyronie, CHRU Montpellier, UM, INSERM U1061, Montpellier, France.

Denis Mariano-Goulart (D)

Département de Médecine Nucléaire, Hôpital Lapeyronie, Centre Hospitalier Régional Universitaire (CHRU) Montpellier, Montpellier, France.
PhyMedExp, Université de Montpellier (UM), INSERM, CNRS, Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH